{"entity":{"type":"insider","cik":"0001580169","url":"/insider/0001580169","json_url":"/insider/0001580169.json","name":"Meridian Venture Partners II, Co.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":11,"first":"2014-03-14","last":"2023-08-16","span_basis":"filed_date"},"name_variants":[{"name":"Meridian Venture Partners II, Co.","source":"filing","n_filings":11,"first_seen":"2014-03-14","last_seen":"2023-08-16"}],"transactions":[{"id":8001263,"accession":"0001104659-23-092750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-092750","line_url":"/filing/0001104659-23-092750#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II, Co.; Meridian Venture Partners II GP, L.P.; Brown Robert E. JR","owner_display_name":"MERIDIAN VENTURE PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":58.5,"price_display":"58.50","price_state":"stated","total_value":11700000.0,"total_display":"11,700,000.00","total_whole":"11,700,000","shares_owned_after":1819259.0,"shares_owned_after_display":"1,819,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-16","scope":"insider"},{"id":6418994,"accession":"0001104659-22-124079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-124079","line_url":"/filing/0001104659-22-124079#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; Meridian Venture Partners II, Co.; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":38.5,"price_display":"38.50","price_state":"stated","total_value":7700000.0,"total_display":"7,700,000.00","total_whole":"7,700,000","shares_owned_after":2019259.0,"shares_owned_after_display":"2,019,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":9237033,"accession":"0001144204-19-041520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-041520","line_url":"/filing/0001144204-19-041520#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.","owner_display_name":"Brown Robert E. JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5512.0,"shares_display":"5,512","price_per_share":68.18,"price_display":"68.18","price_state":"stated","total_value":375808.16,"total_display":"375,808.16","total_whole":"375,808","shares_owned_after":2281283.0,"shares_owned_after_display":"2,281,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-23","scope":"insider"},{"id":8263427,"accession":"0001144204-19-040993","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-040993","line_url":"/filing/0001144204-19-040993#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; MERIDIAN VENTURE PARTNERS II LP; Brown Robert E. JR; Meridian Venture Partners II, Co.","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5512.0,"shares_display":"5,512","price_per_share":68.18,"price_display":"68.18","price_state":"stated","total_value":375808.16,"total_display":"375,808.16","total_whole":"375,808","shares_owned_after":2219259.0,"shares_owned_after_display":"2,219,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-21","scope":"insider"},{"id":9237032,"accession":"0001144204-19-041520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-041520","line_url":"/filing/0001144204-19-041520#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.","owner_display_name":"Brown Robert E. JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2067.0,"shares_display":"2,067","price_per_share":68.3,"price_display":"68.30","price_state":"stated","total_value":141176.1,"total_display":"141,176.10","total_whole":"141,176","shares_owned_after":2286795.0,"shares_owned_after_display":"2,286,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-23","scope":"insider"},{"id":8263419,"accession":"0001144204-19-040993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-040993","line_url":"/filing/0001144204-19-040993#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; MERIDIAN VENTURE PARTNERS II LP; Brown Robert E. JR; Meridian Venture Partners II, Co.","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2067.0,"shares_display":"2,067","price_per_share":68.3,"price_display":"68.30","price_state":"stated","total_value":141176.1,"total_display":"141,176.10","total_whole":"141,176","shares_owned_after":2224771.0,"shares_owned_after_display":"2,224,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":8220585,"accession":"0001144204-19-040452","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-19-040452","line_url":"/filing/0001144204-19-040452#line-3","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26349.0,"shares_display":"26,349","price_per_share":68.09,"price_display":"68.09","price_state":"stated","total_value":1794103.41,"total_display":"1,794,103.41","total_whole":"1,794,103","shares_owned_after":2226838.0,"shares_owned_after_display":"2,226,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-16","scope":"insider"},{"id":8220580,"accession":"0001144204-19-040452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-040452","line_url":"/filing/0001144204-19-040452#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9315.0,"shares_display":"9,315","price_per_share":69.34,"price_display":"69.34","price_state":"stated","total_value":645902.1,"total_display":"645,902.10","total_whole":"645,902","shares_owned_after":2253187.0,"shares_owned_after_display":"2,253,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":8220576,"accession":"0001144204-19-040452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-040452","line_url":"/filing/0001144204-19-040452#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26360.0,"shares_display":"26,360","price_per_share":69.89,"price_display":"69.89","price_state":"stated","total_value":1842300.4,"total_display":"1,842,300.40","total_whole":"1,842,300","shares_owned_after":2262502.0,"shares_owned_after_display":"2,262,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":8524005,"accession":"0001144204-19-039648","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-19-039648","line_url":"/filing/0001144204-19-039648#line-3","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II, Co.","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20821.0,"shares_display":"20,821","price_per_share":71.77,"price_display":"71.77","price_state":"stated","total_value":1494323.17,"total_display":"1,494,323.17","total_whole":"1,494,323","shares_owned_after":2288862.0,"shares_owned_after_display":"2,288,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider"},{"id":8524001,"accession":"0001144204-19-039648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-039648","line_url":"/filing/0001144204-19-039648#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II, Co.","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21016.0,"shares_display":"21,016","price_per_share":71.45,"price_display":"71.45","price_state":"stated","total_value":1501593.2,"total_display":"1,501,593.20","total_whole":"1,501,593","shares_owned_after":2309683.0,"shares_owned_after_display":"2,309,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":8523998,"accession":"0001144204-19-039648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-039648","line_url":"/filing/0001144204-19-039648#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II, Co.","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19860.0,"shares_display":"19,860","price_per_share":71.7,"price_display":"71.70","price_state":"stated","total_value":1423962.0,"total_display":"1,423,962.00","total_whole":"1,423,962","shares_owned_after":2330699.0,"shares_owned_after_display":"2,330,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-13","scope":"insider"},{"id":8810011,"accession":"0001144204-15-016478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-016478","line_url":"/filing/0001144204-15-016478#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II, Co.; Brown Robert E. JR","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":63.0,"price_display":"63.00","price_state":"stated","total_value":18900000.0,"total_display":"18,900,000.00","total_whole":"18,900,000","shares_owned_after":2350559.0,"shares_owned_after_display":"2,350,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-12","filed_date":"2015-03-16","scope":"insider"},{"id":6740118,"accession":"0001144204-14-016959","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-016959","line_url":"/filing/0001144204-14-016959#line-3","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II, Co.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II GP, L.P.","owner_display_name":"Meridian Venture Partners II, Co.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":31.76,"price_display":"31.76","price_state":"stated","total_value":317600.0,"total_display":"317,600.00","total_whole":"317,600","shares_owned_after":2650559.0,"shares_owned_after_display":"2,650,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-20","scope":"insider"},{"id":6740116,"accession":"0001144204-14-016959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-016959","line_url":"/filing/0001144204-14-016959","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II, Co.; Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II GP, L.P.","owner_display_name":"Meridian Venture Partners II, Co.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10922.0,"shares_display":"10,922","price_per_share":32.44738509430507,"price_display":"32.45","price_state":"stated","total_value":354390.34,"total_display":"354,390.34","total_whole":"354,390","shares_owned_after":2661310.0,"shares_owned_after_display":"2,661,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-20","scope":"insider","n_lines":2},{"id":6970234,"accession":"0001144204-14-016516","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-016516","line_url":"/filing/0001144204-14-016516#line-4","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; Meridian Venture Partners II, Co.; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20542.0,"shares_display":"20,542","price_per_share":33.83,"price_display":"33.83","price_state":"stated","total_value":694935.86,"total_display":"694,935.86","total_whole":"694,936","shares_owned_after":2671481.0,"shares_owned_after_display":"2,671,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-18","scope":"insider"},{"id":6970231,"accession":"0001144204-14-016516","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-016516","line_url":"/filing/0001144204-14-016516#line-3","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; Meridian Venture Partners II, Co.; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10339.0,"shares_display":"10,339","price_per_share":34.75,"price_display":"34.75","price_state":"stated","total_value":359280.25,"total_display":"359,280.25","total_whole":"359,280","shares_owned_after":2692023.0,"shares_owned_after_display":"2,692,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-03-18","scope":"insider"},{"id":6970227,"accession":"0001144204-14-016516","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-016516","line_url":"/filing/0001144204-14-016516","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"Meridian Venture Partners II GP, L.P.; Brown Robert E. JR; Meridian Venture Partners II, Co.; MERIDIAN VENTURE PARTNERS II LP","owner_display_name":"Meridian Venture Partners II GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29659.0,"shares_display":"29,659","price_per_share":33.98939242725648,"price_display":"33.99","price_state":"stated","total_value":1008091.39,"total_display":"1,008,091.39","total_whole":"1,008,091","shares_owned_after":2707114.0,"shares_owned_after_display":"2,707,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2014-03-18","scope":"insider","n_lines":2},{"id":9236489,"accession":"0001144204-14-016518","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-016518","line_url":"/filing/0001144204-14-016518","is_derivative":false,"issuer_cik":"0001109507","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001109507","owner_cik":null,"owner_name":"Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.","owner_display_name":"Brown Robert E. JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52404.0,"shares_display":"52,404","price_per_share":31.683992824975192,"price_display":"31.68","price_state":"stated","total_value":1660367.96,"total_display":"1,660,367.96","total_whole":"1,660,368","shares_owned_after":2750911.0,"shares_owned_after_display":"2,750,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-13","filed_date":"2014-03-18","scope":"insider","n_lines":3},{"id":6435826,"accession":"0001144204-14-015904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-015904","line_url":"/filing/0001144204-14-015904#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"MERIDIAN VENTURE PARTNERS II LP; Brown Robert E. JR; Meridian Venture Partners II, Co.; Meridian Venture Partners II GP, L.P.","owner_display_name":"MERIDIAN VENTURE PARTNERS II LP","owner_url":null,"role":"Director, Officer (Chairman), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52404.0,"shares_display":"52,404","price_per_share":31.69,"price_display":"31.69","price_state":"stated","total_value":1660682.76,"total_display":"1,660,682.76","total_whole":"1,660,683","shares_owned_after":16830746.0,"shares_owned_after_display":"16,830,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-13","filed_date":"2014-03-14","scope":"insider"},{"id":9236488,"accession":"0001144204-14-016518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-016518","line_url":"/filing/0001144204-14-016518","is_derivative":false,"issuer_cik":"0001109507","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001109507","owner_cik":null,"owner_name":"Brown Robert E. JR; MERIDIAN VENTURE PARTNERS II LP; Meridian Venture Partners II GP, L.P.; Meridian Venture Partners II, Co.","owner_display_name":"Brown Robert E. JR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35319.0,"shares_display":"35,319","price_per_share":33.661310626008664,"price_display":"33.66","price_state":"stated","total_value":1188883.83,"total_display":"1,188,883.83","total_whole":"1,188,884","shares_owned_after":2784425.0,"shares_owned_after_display":"2,784,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-12","filed_date":"2014-03-18","scope":"insider","n_lines":2},{"id":6435822,"accession":"0001144204-14-015904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-015904","line_url":"/filing/0001144204-14-015904#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":null,"owner_name":"MERIDIAN VENTURE PARTNERS II LP; Brown Robert E. JR; Meridian Venture Partners II, Co.; Meridian Venture Partners II GP, L.P.","owner_display_name":"MERIDIAN VENTURE PARTNERS II LP","owner_url":null,"role":"Director, Officer (Chairman), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35319.0,"shares_display":"35,319","price_per_share":33.66,"price_display":"33.66","price_state":"stated","total_value":1188837.54,"total_display":"1,188,837.54","total_whole":"1,188,838","shares_owned_after":16883150.0,"shares_owned_after_display":"16,883,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-12","filed_date":"2014-03-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001023024","name":"ANI PHARMACEUTICALS INC","url":"/issuer/0001023024","role":"Ten percent owner","n_filings":11,"first_seen":"2014-03-14","last_seen":"2023-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001580169","retrieved_at":"2026-08-25T09:50:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}